Research & Development
24 September 2021 - - US-based biotechnology and pharmaceutical company Reven Holdings, Inc has completed Part 1 of the Two-Part, Two Cohort Multi-Center Phase I/II trial of Reven's lead anti-sep...
24 September 2021 - - New data has been published highlighting the sustained benefits of treatment with Crysvita (burosumab) in adults with X-linked hypophosphataemia, a rare genetic metabolic bone di...
24 September 2021 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) has inked a supply agreement with the government of Peru for 20 m doses of Moderna's COVID-19 vaccine to beg...
24 September 2021 - Healthcare company Baxter International Inc (NYSE:BAX) announced on Thursday the commercial availability of premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrin...
24 September 2021 - Immuno oncology company Targovax ASA (OSE:TRVX) reported on Friday the receipt of the EU Patent covering the use of its lead product candidate, ONCOS-102 in combination with chemot...
23 September 2021 - - US-based gene therapy company Taysha Gene Therapies, Inc. (NASDAQ: TSHA) has been granted orphan drug designation from the European Commission for TSHA-102, an AAV9-based gene re...
Related Headlines